ESC 2018: Report From the SCAAR Registry

Published: 14 Sep 2018

  • Views:

    Views Icon 156
  • Likes:

    Heart Icon 0

Prof Elmir Omerovic (University of Gothenburg, Gothenburg, SE) discusses updates from SCAAR registry - Pretreatment with P2Y12 Receptor Antagonists is not Associated with Improved Clinical Outcomes in UA/NSTEMI.

Filmed on-site at ESC 2018, Munich.